Veradigm (MDRX) Competitors $8.52 -0.49 (-5.39%) As of 10:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSustainabilityTrends MDRX vs. OMCL, HSTM, CRTX, AGYS, VRNT, NTCT, DMRC, ECX, OSPN, and RBBNShould you be buying Veradigm stock or one of its competitors? The main competitors of Veradigm include Omnicell (OMCL), HealthStream (HSTM), Cortexyme (CRTX), Agilysys (AGYS), Verint Systems (VRNT), NetScout Systems (NTCT), Digimarc (DMRC), ECARX (ECX), OneSpan (OSPN), and Ribbon Communications (RBBN). Veradigm vs. Omnicell HealthStream Cortexyme Agilysys Verint Systems NetScout Systems Digimarc ECARX OneSpan Ribbon Communications Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends. Does the MarketBeat Community believe in MDRX or OMCL? Veradigm received 130 more outperform votes than Omnicell when rated by MarketBeat users. However, 66.89% of users gave Omnicell an outperform vote while only 58.46% of users gave Veradigm an outperform vote. CompanyUnderperformOutperformVeradigmOutperform Votes62958.46% Underperform Votes44741.54% OmnicellOutperform Votes49966.89% Underperform Votes24733.11% Which has more risk and volatility, MDRX or OMCL? Veradigm has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Do analysts recommend MDRX or OMCL? Veradigm currently has a consensus target price of $12.50, suggesting a potential upside of 46.80%. Omnicell has a consensus target price of $50.00, suggesting a potential upside of 17.67%. Given Veradigm's stronger consensus rating and higher possible upside, equities analysts plainly believe Veradigm is more favorable than Omnicell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veradigm 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Omnicell 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do institutionals & insiders believe in MDRX or OMCL? 97.7% of Omnicell shares are held by institutional investors. 2.3% of Veradigm shares are held by company insiders. Comparatively, 2.6% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to MDRX or OMCL? In the previous week, Veradigm and Veradigm both had 2 articles in the media. Omnicell's average media sentiment score of 1.10 beat Veradigm's score of 0.58 indicating that Omnicell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veradigm 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Omnicell 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, MDRX or OMCL? Veradigm has higher earnings, but lower revenue than Omnicell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeradigmN/AN/AN/AN/AN/AOmnicell$1.15B1.72-$20.37M-$0.39-108.95 Is MDRX or OMCL more profitable? Veradigm has a net margin of 0.00% compared to Omnicell's net margin of -1.66%. Omnicell's return on equity of 2.55% beat Veradigm's return on equity.Company Net Margins Return on Equity Return on Assets VeradigmN/A N/A N/A Omnicell -1.66%2.55%1.35% SummaryOmnicell beats Veradigm on 9 of the 13 factors compared between the two stocks. Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDRX vs. The Competition Export to ExcelMetricVeradigmComputer integrated systems design IndustryBusiness SectorNASDAQ ExchangeMarket Cap$916.56M$3.99B$7.47B$9.26BDividend YieldN/A2.00%2.23%3.99%P/E RatioN/A15.4728.6017.56Price / SalesN/A25.52106.2778.60Price / CashN/A38.1130.5936.96Price / BookN/A20.156.184.73Net IncomeN/A$27.28M$136.88M$224.57M7 Day Performance-8.54%-0.91%1.52%1.62%1 Month Performance-10.37%12.42%5.41%5.25%1 Year Performance-10.27%16.77%22.91%21.39% Veradigm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDRXVeradigm2.9213 of 5 stars$8.52-5.4%$12.50+46.8%-0.2%$916.56MN/A0.008,000Analyst ForecastGap DownOMCLOmnicell3.6044 of 5 stars$42.22-0.1%$50.00+18.4%+31.1%$1.96B$1.06B-108.253,650Positive NewsHSTMHealthStream4.3746 of 5 stars$31.25-0.4%$31.50+0.8%+17.3%$950.47M$287.99M48.081,140News CoveragePositive NewsCRTXCortexymeN/A$1.79-4.8%N/A+23.0%$53.97MN/A-0.6055Positive NewsGap UpAGYSAgilysys4.5956 of 5 stars$126.15-1.5%$146.00+15.7%+52.0%$3.53B$254.58M35.941,400Earnings ReportAnalyst ForecastInsider TradeShort Interest ↑News CoverageGap DownVRNTVerint Systems4.5184 of 5 stars$24.70-2.1%$35.67+44.4%-13.1%$1.54B$920.75M26.283,700NTCTNetScout Systems1.5477 of 5 stars$21.33+0.0%$22.00+3.1%+3.6%$1.53B$787.19M-2.542,296Upcoming EarningsDMRCDigimarc0.5372 of 5 stars$40.10-5.2%$34.00-15.2%+15.1%$858.94M$34.85M-20.56230Positive NewsECXECARX0.3433 of 5 stars$2.22+1.4%N/A-23.7%$750.25M$5.46B-4.442,020Analyst RevisionOSPNOneSpan4.4221 of 5 stars$18.34+0.3%$17.63-3.9%+81.7%$696.76M$244.94M24.78526RBBNRibbon Communications4.5243 of 5 stars$3.88-1.8%$6.00+54.6%+38.9%$680.49M$808.92M-12.123,107 Related Companies and Tools Related Companies Omnicell Competitors HealthStream Competitors Cortexyme Competitors Agilysys Competitors Verint Systems Competitors NetScout Systems Competitors Digimarc Competitors ECARX Competitors OneSpan Competitors Ribbon Communications Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MDRX) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDRX Stock Alerts